Pipeline

Pipeline
Edsivo™ (celiprolol) for vEDS
Vascular Ehlers-Danlos Syndrome (vEDS)
Edsivo™ (celiprolol) for vEDS
Patient Resources
Physician Resources
ACER-001 for UCD
Diagnosis
Management
ACER-001 for UCDs
Patient Resources
Physician Resources
ACER-001 for MSUD
Types of MSUD
Diagnosis
Management
ACER-001 for MSUD
Patient Resources
Physician Resources

Acer Therapeutics is developing therapies for serious rare diseases with significant unmet need. We are working to obtain FDA approval for Edsivo™(celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the US. We are also advancing ACER-001 for the treatment of Maple Syrup Urine Disease (MSUD) and Urea Cycle Disorders (UCDs).